Lynk Pharmaceuticals Announces NDA Acceptance for Zemprocitinib by NMPA

B SHANGHAI, HANGZHOU, China and BOSTON, April 10, 2026 /PRNewswire/ — Lynk Pharmaceuticals Co., Ltd. (“Lynk Pharmaceuticals”), a clinical-stage innovative drug development company focused on…
posteditor
posteditor
Articles: 16137

Other News